Selected highlights from the American Academy of Neurology annual meeting, Boston, MA, 22-27 April 2023.
April 25 Edition
April 24 Edition
COVID-19 infections with ocrelizumab
Postpartum relapse and DMTs
NMOSD frequently misdiagnosed
sNfL after menopause
Pregnancy risks with fingolimod
Phase II study of stem-cell therapy in PMS
Low rate of ocrelizumab failure
DMT non-starters common in California
Read More
Selected highlights from the American Academy of Neurology annual meeting, Boston, MA, 22-27 April 2023.
April 26 Edition
April 24 Edition
Bruton’s tyrosine kinase (BTK) inhibitors – an update
EBV antibodies not useful for prognosis
Novel imaging studies in RIS
Read More
Selected highlights from the American Academy of Neurology annual meeting, Boston, MA, 22-27 April 2023.
April 26 Edition
April 25 Edition
Combining sNfL and cGFAP improves prognostic value
NfL/GFAP changes during anti-CD20 treatment
How is JC virus transmitted?
Does body weight affect B cell kinetics?
Hyperglycemia medications and MS risk
Read More
Periodic assessment of serum neurofilament-light chain (sNfL) may be useful to identify subclinical disease activity, according to an analysis from the APLIOS study (Bar-Or et al. Neurol Ther 2023;12:303-317). Read More